John Michael Kelley, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placebo Effect | 21 | 2021 | 502 | 3.460 |
Why?
|
| Irritable Bowel Syndrome | 16 | 2022 | 445 | 2.300 |
Why?
|
| Placebos | 10 | 2022 | 1677 | 0.860 |
Why?
|
| Antiparkinson Agents | 2 | 2015 | 184 | 0.730 |
Why?
|
| Physician-Patient Relations | 10 | 2018 | 3227 | 0.630 |
Why?
|
| Classification | 1 | 2018 | 129 | 0.630 |
Why?
|
| Acupuncture Therapy | 9 | 2023 | 464 | 0.590 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 500 | 0.460 |
Why?
|
| Empathy | 5 | 2023 | 472 | 0.450 |
Why?
|
| Marriage | 1 | 2013 | 339 | 0.390 |
Why?
|
| Consensus | 3 | 2021 | 2958 | 0.380 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2017 | 9960 | 0.360 |
Why?
|
| Ceremonial Behavior | 1 | 2008 | 18 | 0.330 |
Why?
|
| Plant Oils | 2 | 2021 | 202 | 0.330 |
Why?
|
| Research Subjects | 1 | 2010 | 239 | 0.320 |
Why?
|
| Interpersonal Relations | 2 | 2013 | 1424 | 0.310 |
Why?
|
| Parkinson Disease | 2 | 2015 | 2776 | 0.300 |
Why?
|
| Clonazepam | 2 | 2017 | 136 | 0.290 |
Why?
|
| Burning Mouth Syndrome | 2 | 2017 | 32 | 0.290 |
Why?
|
| Treatment Outcome | 19 | 2023 | 63119 | 0.290 |
Why?
|
| Sensory Thresholds | 1 | 2008 | 394 | 0.290 |
Why?
|
| Touch | 1 | 2008 | 306 | 0.270 |
Why?
|
| Tai Ji | 1 | 2008 | 285 | 0.250 |
Why?
|
| Complementary Therapies | 1 | 2008 | 486 | 0.240 |
Why?
|
| Nonverbal Communication | 2 | 2022 | 63 | 0.240 |
Why?
|
| Double-Blind Method | 7 | 2022 | 12035 | 0.220 |
Why?
|
| Self Care | 1 | 2008 | 786 | 0.220 |
Why?
|
| Dyspepsia | 1 | 2023 | 115 | 0.220 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2014 | 245 | 0.200 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2022 | 434 | 0.180 |
Why?
|
| Patient Satisfaction | 5 | 2011 | 3395 | 0.180 |
Why?
|
| Neuronal Plasticity | 1 | 2008 | 1422 | 0.170 |
Why?
|
| Gastrointestinal Agents | 2 | 2017 | 494 | 0.170 |
Why?
|
| Catastrophization | 1 | 2022 | 316 | 0.160 |
Why?
|
| Motivation | 1 | 2008 | 1971 | 0.160 |
Why?
|
| Skin | 2 | 2009 | 4363 | 0.160 |
Why?
|
| Learning | 1 | 2008 | 1713 | 0.160 |
Why?
|
| Leukopoiesis | 1 | 2018 | 56 | 0.160 |
Why?
|
| Fish Proteins | 1 | 2018 | 46 | 0.160 |
Why?
|
| Attention | 1 | 2008 | 2399 | 0.150 |
Why?
|
| Research Design | 4 | 2022 | 5987 | 0.150 |
Why?
|
| Adult | 27 | 2022 | 214035 | 0.140 |
Why?
|
| Pain Measurement | 4 | 2022 | 3419 | 0.140 |
Why?
|
| Paresthesia | 1 | 2017 | 162 | 0.140 |
Why?
|
| Humans | 53 | 2023 | 744220 | 0.140 |
Why?
|
| Chemokine CXCL12 | 1 | 2018 | 464 | 0.130 |
Why?
|
| Phototherapy | 2 | 2009 | 377 | 0.130 |
Why?
|
| Abdominal Pain | 1 | 2022 | 1062 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2010 | 3311 | 0.120 |
Why?
|
| Depressive Disorder, Major | 1 | 2012 | 4645 | 0.120 |
Why?
|
| Endpoint Determination | 2 | 2014 | 601 | 0.120 |
Why?
|
| Female | 32 | 2022 | 380197 | 0.120 |
Why?
|
| Personality | 2 | 2014 | 552 | 0.120 |
Why?
|
| Anticipation, Psychological | 1 | 2014 | 87 | 0.120 |
Why?
|
| Male | 31 | 2022 | 350027 | 0.110 |
Why?
|
| Sex Characteristics | 2 | 2014 | 2586 | 0.110 |
Why?
|
| Receptors, CXCR4 | 1 | 2018 | 726 | 0.110 |
Why?
|
| Courtship | 1 | 2013 | 32 | 0.110 |
Why?
|
| Pain Perception | 1 | 2014 | 191 | 0.110 |
Why?
|
| Watchful Waiting | 1 | 2017 | 491 | 0.110 |
Why?
|
| Psychological Theory | 1 | 2013 | 168 | 0.100 |
Why?
|
| Drug Labeling | 1 | 2014 | 232 | 0.100 |
Why?
|
| Therapeutic Touch | 1 | 2011 | 8 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 2 | 2013 | 2715 | 0.100 |
Why?
|
| Anxiety | 3 | 2022 | 4297 | 0.100 |
Why?
|
| Physical Stimulation | 2 | 2014 | 525 | 0.100 |
Why?
|
| Albuterol | 1 | 2011 | 208 | 0.090 |
Why?
|
| Mentha piperita | 2 | 2021 | 16 | 0.090 |
Why?
|
| Analgesia | 1 | 2014 | 462 | 0.090 |
Why?
|
| Leukocytes | 1 | 2018 | 2040 | 0.090 |
Why?
|
| Physicians | 2 | 2023 | 4564 | 0.090 |
Why?
|
| Middle Aged | 19 | 2022 | 213367 | 0.090 |
Why?
|
| Osteoprotegerin | 1 | 2009 | 176 | 0.080 |
Why?
|
| Lasers, Semiconductor | 1 | 2009 | 46 | 0.080 |
Why?
|
| Flowers | 1 | 2008 | 28 | 0.080 |
Why?
|
| Pilot Projects | 4 | 2022 | 8321 | 0.080 |
Why?
|
| Psychoanalytic Therapy | 1 | 2010 | 230 | 0.080 |
Why?
|
| Sexual Partners | 1 | 2013 | 730 | 0.080 |
Why?
|
| Facial Dermatoses | 1 | 2009 | 87 | 0.080 |
Why?
|
| Pediatrics | 1 | 2023 | 3469 | 0.080 |
Why?
|
| Waiting Lists | 2 | 2009 | 693 | 0.080 |
Why?
|
| Bronchodilator Agents | 1 | 2011 | 502 | 0.080 |
Why?
|
| Skin Aging | 1 | 2009 | 127 | 0.080 |
Why?
|
| Neurosciences | 1 | 2012 | 348 | 0.080 |
Why?
|
| Afferent Pathways | 1 | 2008 | 302 | 0.070 |
Why?
|
| Cosmetic Techniques | 1 | 2009 | 135 | 0.070 |
Why?
|
| Brain | 3 | 2023 | 26413 | 0.070 |
Why?
|
| Orientation | 1 | 2008 | 327 | 0.070 |
Why?
|
| Discrimination Learning | 1 | 2008 | 280 | 0.070 |
Why?
|
| Time | 1 | 2008 | 541 | 0.070 |
Why?
|
| Quality of Life | 5 | 2023 | 12805 | 0.070 |
Why?
|
| Personality Inventory | 1 | 2009 | 1030 | 0.070 |
Why?
|
| Blepharoplasty | 1 | 2006 | 50 | 0.070 |
Why?
|
| Posture | 1 | 2010 | 958 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 3385 | 0.070 |
Why?
|
| Administration, Topical | 2 | 2017 | 689 | 0.070 |
Why?
|
| Interviews as Topic | 4 | 2017 | 2539 | 0.060 |
Why?
|
| Fingers | 1 | 2008 | 514 | 0.060 |
Why?
|
| Blepharoptosis | 1 | 2006 | 144 | 0.060 |
Why?
|
| Plant Extracts | 1 | 2008 | 472 | 0.060 |
Why?
|
| Space Perception | 1 | 2008 | 475 | 0.060 |
Why?
|
| Video Recording | 1 | 2009 | 947 | 0.060 |
Why?
|
| Eyelids | 1 | 2006 | 265 | 0.060 |
Why?
|
| Spirituality | 1 | 2008 | 405 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2009 | 2297 | 0.060 |
Why?
|
| Somatosensory Cortex | 1 | 2008 | 528 | 0.060 |
Why?
|
| Otolaryngology | 1 | 2011 | 645 | 0.060 |
Why?
|
| Deception | 2 | 2017 | 99 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2012 | 6037 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7179 | 0.060 |
Why?
|
| Regression Analysis | 2 | 2012 | 6461 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2022 | 8628 | 0.060 |
Why?
|
| Headache | 2 | 2022 | 1226 | 0.060 |
Why?
|
| Gastroesophageal Reflux | 1 | 2010 | 782 | 0.050 |
Why?
|
| Patients | 1 | 2009 | 900 | 0.050 |
Why?
|
| Pain | 4 | 2022 | 4987 | 0.050 |
Why?
|
| Republic of Korea | 1 | 2023 | 539 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2014 | 3591 | 0.050 |
Why?
|
| Migraine Disorders | 1 | 2014 | 1624 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2017 | 4687 | 0.050 |
Why?
|
| Internship and Residency | 2 | 2012 | 5787 | 0.050 |
Why?
|
| Adolescent | 5 | 2022 | 85759 | 0.050 |
Why?
|
| Metronidazole | 1 | 2022 | 217 | 0.050 |
Why?
|
| Injections, Intramuscular | 1 | 2022 | 548 | 0.050 |
Why?
|
| Arm Injuries | 1 | 2022 | 160 | 0.050 |
Why?
|
| Ciprofloxacin | 1 | 2022 | 315 | 0.040 |
Why?
|
| Social Support | 1 | 2009 | 2117 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2012 | 2291 | 0.040 |
Why?
|
| Child | 3 | 2023 | 77679 | 0.040 |
Why?
|
| Research | 2 | 2021 | 1999 | 0.040 |
Why?
|
| Facial Expression | 1 | 2022 | 508 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2010 | 10250 | 0.040 |
Why?
|
| Benzylamines | 1 | 2018 | 226 | 0.040 |
Why?
|
| Mouthwashes | 1 | 2017 | 59 | 0.040 |
Why?
|
| Personality Disorders | 1 | 2001 | 713 | 0.040 |
Why?
|
| Heterocyclic Compounds | 1 | 2018 | 249 | 0.040 |
Why?
|
| Solutions | 1 | 2017 | 426 | 0.040 |
Why?
|
| Aged | 7 | 2017 | 163253 | 0.030 |
Why?
|
| Age Factors | 1 | 2013 | 18367 | 0.030 |
Why?
|
| Feces | 1 | 2022 | 1402 | 0.030 |
Why?
|
| Palliative Care | 1 | 2010 | 3490 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 6991 | 0.030 |
Why?
|
| Asthma | 2 | 2011 | 6011 | 0.030 |
Why?
|
| Wound Healing | 1 | 2006 | 2785 | 0.030 |
Why?
|
| Single-Blind Method | 2 | 2009 | 1590 | 0.030 |
Why?
|
| Time Factors | 3 | 2017 | 40063 | 0.030 |
Why?
|
| Fatigue | 1 | 2022 | 1531 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2009 | 2425 | 0.030 |
Why?
|
| Functional Laterality | 2 | 2014 | 2290 | 0.030 |
Why?
|
| Tryptamines | 1 | 2014 | 88 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 15525 | 0.030 |
Why?
|
| Forearm | 1 | 2014 | 409 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 7908 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2017 | 1462 | 0.020 |
Why?
|
| Bacteria | 1 | 2022 | 2114 | 0.020 |
Why?
|
| Phylogeny | 1 | 2018 | 2803 | 0.020 |
Why?
|
| Pain Threshold | 1 | 2014 | 585 | 0.020 |
Why?
|
| Young Adult | 5 | 2017 | 56436 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2022 | 15538 | 0.020 |
Why?
|
| Physician's Role | 1 | 2017 | 942 | 0.020 |
Why?
|
| Tumor Necrosis Factors | 1 | 2009 | 109 | 0.020 |
Why?
|
| Psychoanalysis | 1 | 2010 | 87 | 0.020 |
Why?
|
| Touch Perception | 1 | 2011 | 114 | 0.020 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2011 | 230 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2023 | 3842 | 0.020 |
Why?
|
| Aging | 1 | 2008 | 8661 | 0.020 |
Why?
|
| Sensation | 1 | 2011 | 337 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2014 | 1355 | 0.020 |
Why?
|
| Rejuvenation | 1 | 2009 | 91 | 0.020 |
Why?
|
| Triazoles | 1 | 2014 | 911 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 57768 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 1792 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2023 | 6671 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2009 | 981 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2023 | 5709 | 0.020 |
Why?
|
| Social Isolation | 1 | 2009 | 365 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2011 | 1744 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 13096 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2011 | 2032 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 35423 | 0.020 |
Why?
|
| United States | 1 | 2013 | 69867 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2886 | 0.010 |
Why?
|
| Follow-Up Studies | 3 | 2011 | 39045 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2010 | 2374 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 3509 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 25043 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 12075 | 0.010 |
Why?
|
| Perception | 1 | 2006 | 1198 | 0.010 |
Why?
|
| Patient-Centered Care | 1 | 2009 | 1438 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2014 | 6546 | 0.010 |
Why?
|
| Curriculum | 1 | 2012 | 3604 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2017 | 77426 | 0.010 |
Why?
|
| Interview, Psychological | 1 | 2001 | 812 | 0.010 |
Why?
|
| Genotype | 1 | 2012 | 12956 | 0.010 |
Why?
|
| Patient Selection | 1 | 2009 | 4216 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2018 | 23404 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2009 | 53280 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 29050 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 19907 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 168788 | 0.000 |
Why?
|